Axsome Therapeutics
AXSM
AXSM
36 hedge funds and large institutions have $10.4M invested in Axsome Therapeutics in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
68% less capital invested
Capital invested by funds: $32.6M → $10.4M (-$22.2M)
Holders
36
Holding in Top 10
–
Calls
$38K
Puts
$2K
Top Buyers
| 1 | +$474K | |
| 2 | +$199K | |
| 3 | +$184K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$145K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$108K |
Top Sellers
| 1 | -$3.13M | |
| 2 | -$1.69M | |
| 3 | -$705K | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$704K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$549K |